HUT72300A - New triazolopyrimidones, their production and their use - Google Patents
New triazolopyrimidones, their production and their use Download PDFInfo
- Publication number
- HUT72300A HUT72300A HU9501692A HU9501692A HUT72300A HU T72300 A HUT72300 A HU T72300A HU 9501692 A HU9501692 A HU 9501692A HU 9501692 A HU9501692 A HU 9501692A HU T72300 A HUT72300 A HU T72300A
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- alkyl
- group
- compounds
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4241562A DE4241562A1 (de) | 1992-12-10 | 1992-12-10 | Neue Triazolopyrimidone, ihre Herstellung und Verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9501692D0 HU9501692D0 (en) | 1995-08-28 |
| HUT72300A true HUT72300A (en) | 1996-04-29 |
Family
ID=6474848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9501692A HUT72300A (en) | 1992-12-10 | 1993-11-27 | New triazolopyrimidones, their production and their use |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5654310A (xx) |
| EP (1) | EP0673378B1 (xx) |
| JP (1) | JP3490445B2 (xx) |
| CN (1) | CN1098414A (xx) |
| AT (1) | ATE150023T1 (xx) |
| AU (1) | AU674371B2 (xx) |
| CA (1) | CA2151243A1 (xx) |
| CZ (1) | CZ144995A3 (xx) |
| DE (2) | DE4241562A1 (xx) |
| DK (1) | DK0673378T3 (xx) |
| ES (1) | ES2099577T3 (xx) |
| FI (1) | FI952856A (xx) |
| GR (1) | GR3022980T3 (xx) |
| HU (1) | HUT72300A (xx) |
| IL (1) | IL107916A (xx) |
| MX (1) | MX9307735A (xx) |
| NO (1) | NO952291L (xx) |
| NZ (1) | NZ258558A (xx) |
| PL (1) | PL309329A1 (xx) |
| RU (1) | RU95121818A (xx) |
| WO (1) | WO1994013673A1 (xx) |
| ZA (1) | ZA939228B (xx) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4053600A (en) * | 1973-03-08 | 1977-10-11 | Sandoz, Inc. | Tricyclic 1,2,4-triazolo-quinazolines |
| US4128644A (en) * | 1977-07-29 | 1978-12-05 | E. R. Squibb & Sons, Inc. | Pyrazolo(1,5-c)quinazoline derivatives and related compounds |
| DE3146599A1 (de) * | 1981-11-25 | 1983-07-07 | Basf Ag, 6700 Ludwigshafen | Neue triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
| EP0217748B1 (en) * | 1985-09-30 | 1991-02-06 | Ciba-Geigy Ag | 2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof |
| US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
-
1992
- 1992-12-10 DE DE4241562A patent/DE4241562A1/de not_active Withdrawn
-
1993
- 1993-11-27 CZ CZ951449A patent/CZ144995A3/cs unknown
- 1993-11-27 EP EP94901898A patent/EP0673378B1/de not_active Expired - Lifetime
- 1993-11-27 HU HU9501692A patent/HUT72300A/hu unknown
- 1993-11-27 AU AU56285/94A patent/AU674371B2/en not_active Ceased
- 1993-11-27 NZ NZ258558A patent/NZ258558A/en unknown
- 1993-11-27 RU RU95121818/04A patent/RU95121818A/ru unknown
- 1993-11-27 ES ES94901898T patent/ES2099577T3/es not_active Expired - Lifetime
- 1993-11-27 DK DK94901898.0T patent/DK0673378T3/da active
- 1993-11-27 AT AT94901898T patent/ATE150023T1/de not_active IP Right Cessation
- 1993-11-27 WO PCT/EP1993/003332 patent/WO1994013673A1/de not_active Application Discontinuation
- 1993-11-27 DE DE59305812T patent/DE59305812D1/de not_active Expired - Fee Related
- 1993-11-27 PL PL93309329A patent/PL309329A1/xx unknown
- 1993-11-27 CA CA002151243A patent/CA2151243A1/en not_active Abandoned
- 1993-11-27 JP JP51372594A patent/JP3490445B2/ja not_active Expired - Fee Related
- 1993-12-07 IL IL10791693A patent/IL107916A/en not_active IP Right Cessation
- 1993-12-08 MX MX9307735A patent/MX9307735A/es unknown
- 1993-12-09 ZA ZA939228A patent/ZA939228B/xx unknown
- 1993-12-10 CN CN93121679A patent/CN1098414A/zh active Pending
-
1995
- 1995-06-01 US US08/446,838 patent/US5654310A/en not_active Expired - Fee Related
- 1995-06-09 NO NO952291A patent/NO952291L/no unknown
- 1995-06-09 FI FI952856A patent/FI952856A/fi not_active Application Discontinuation
-
1997
- 1997-03-31 GR GR970400656T patent/GR3022980T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL107916A0 (en) | 1994-04-12 |
| CA2151243A1 (en) | 1994-06-23 |
| WO1994013673A1 (de) | 1994-06-23 |
| IL107916A (en) | 1996-09-12 |
| EP0673378B1 (de) | 1997-03-12 |
| DK0673378T3 (da) | 1997-07-21 |
| JPH08504412A (ja) | 1996-05-14 |
| ES2099577T3 (es) | 1997-05-16 |
| EP0673378A1 (de) | 1995-09-27 |
| PL309329A1 (en) | 1995-10-02 |
| FI952856A0 (fi) | 1995-06-09 |
| FI952856A (fi) | 1995-06-09 |
| AU5628594A (en) | 1994-07-04 |
| MX9307735A (es) | 1994-06-30 |
| JP3490445B2 (ja) | 2004-01-26 |
| GR3022980T3 (en) | 1997-06-30 |
| DE59305812D1 (de) | 1997-04-17 |
| DE4241562A1 (de) | 1994-06-16 |
| NO952291D0 (no) | 1995-06-09 |
| HU9501692D0 (en) | 1995-08-28 |
| CZ144995A3 (en) | 1995-12-13 |
| RU95121818A (ru) | 1997-06-10 |
| ZA939228B (en) | 1995-06-09 |
| CN1098414A (zh) | 1995-02-08 |
| AU674371B2 (en) | 1996-12-19 |
| US5654310A (en) | 1997-08-05 |
| ATE150023T1 (de) | 1997-03-15 |
| NZ258558A (en) | 1997-06-24 |
| NO952291L (no) | 1995-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2648793B2 (ja) | ８ａ，９−ジヒドロ−１Ｈ−ジイミダゾ〔１，５−ａ：４′，５′−ｄ〕ピリジン誘導体 | |
| Suzuki et al. | Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure | |
| KR102401743B1 (ko) | 페닐 프로판아미드 유도체와 이를 제조하는 방법, 및 이를 약학적으로 사용하는 방법 | |
| NO310512B1 (no) | 5H-Tiazolo [3,2-a] pyrimidinderivater | |
| US20210300944A1 (en) | Fused tricyclic heterocycle compounds and therapeutic uses thereof | |
| KR20020064327A (ko) | 아데노신 ａ3, ａ2ａ 및 ａ3 수용체 특이 화합물 및 그의사용방법 | |
| CA2326383A1 (en) | Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors | |
| CA2415683C (en) | Indoloquinazolinones | |
| CA2344828A1 (en) | ¬1,2,4|triazolo¬1,5-c|pyrimidine derivatives | |
| TWI293301B (en) | A1 adenosine receptor antagonists | |
| AU683062B2 (en) | (1,2,4)triazolo(4,3-a)quinoxaline compounds, their preparation and use | |
| CA2158545A1 (en) | [1,2,4,]triazolo[4,3-a]quinaxoline derivatives, their preparation and use | |
| EP1400522B1 (en) | Compounds for treating impotence | |
| EP0743945B1 (en) | Heterocyclic compounds and their preparation and use | |
| CZ246495A3 (en) | Imidazolequinoline derivative as eaa antagonist | |
| HUT72300A (en) | New triazolopyrimidones, their production and their use | |
| EP0511152A2 (en) | Quinoxaline compounds, their preparation and use | |
| EP1025101B1 (en) | Naphtho-imidazo 1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders | |
| CA2084736A1 (en) | Benzofuranes | |
| Baraldi et al. | Synthesis and antitumor activity of a new class of pyrazolo [4, 3-e] pyrrolo [1, 2-a][1, 4] diazepinone analogs of pyrrolo [1, 4] benzodiazepines (PBDs) | |
| US5631261A (en) | Triazoloquinazolines, their preparation and use | |
| US6407109B1 (en) | Pyrrolyl tetrahydroquinoxalin diones, their production and use in the treatment of diseases | |
| US3795674A (en) | Certain 2-substituted-4,6-diamino-5-pyrimidinecarboxaldehydes | |
| JP2001524927A (ja) | ５，６，７，８―テトラヒドロピリド［２，３―ｄ］ピリミジン類 | |
| JPH06145144A (ja) | 新規な３−アミノピリジン誘導体第４級アンモニウム塩及びこれを有効成分とする抗癌剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFA9 | Temporary protection cancelled due to abandonment |